What the research shows
A six-month randomized trial compared oral choline alfoscerate with placebo in adults diagnosed with mild to moderate Alzheimer’s disease. Cognitive test scores favored the active group. The participants and outcome matter when evaluating claims about memory in healthy adults. Read the placebo-controlled clinical trial.
Documented formats
The investigators used oral capsules. A report on the capsule preparation cannot establish that a powder with a different amount of active ingredient delivers the same exposure.
Testing and purity
For a powder sold with a carrier, look for the measured amount of choline alfoscerate per gram of mixture. A certificate must make clear whether a percentage refers to the raw ingredient or the final blend.
How to read a batch reportQuestions about Alpha-GPC
Why is Alpha-GPC in a peptide catalog?
It appears alongside peptides in source guides, but its structure contains a glycerophosphate and choline. It belongs with the related compounds.
Does an Alpha-GPC weight give the weight of choline alone?
The listed molecule contains other chemical groups. Read which substance the label or laboratory quantified before comparing amounts.